Weight Loss & Metabolic Health
How Much Weight Can You Lose on GLP-1 Therapy?
Last reviewed: May 2026 · Haute MD Editorial Team
On average, adults without diabetes lose about 15% of body weight on semaglutide (Wegovy) over 68 weeks and roughly 21% on tirzepatide (Zepbound) at the highest dose over 72 weeks. Top responders lose 25% or more. Patients with type 2 diabetes generally lose somewhat less. Results are significantly improved by adequate protein, resistance training, sleep, and a structured medical program — and significantly worsened by stopping the medication prematurely.
Average and best-case results by medication
STEP-1 trial of semaglutide 2.4 mg (Wegovy): 14.9% average loss over 68 weeks, with one-third of patients losing 20% or more. SURMOUNT-1 trial of tirzepatide 15 mg (Zepbound): 20.9% average loss over 72 weeks, with one-third losing 25% or more. Liraglutide (Saxenda): roughly 5-8% average loss. Patients with type 2 diabetes typically lose somewhat less because diabetes blunts weight loss across all interventions. SURMOUNT-5 head-to-head data showed tirzepatide producing meaningfully greater loss than semaglutide.
Timeline of weight loss
Most weight loss happens in the first 4-8 months. The trajectory is typically: 5% loss by month 3, 10% by month 6, 15% by month 12, and peak around month 17-22 for tirzepatide and 16-18 for semaglutide. After peak, weight tends to stabilize as long as therapy continues. Plateaus during titration are normal and often resolve at the next dose step. Adherence and dose tolerance are the largest predictors of total result.
What improves and what hurts your results
Improves results: tolerating the full therapeutic dose, eating 0.7-1.0 g protein per pound of goal body weight, resistance training 2-3 times weekly, 7-9 hours of sleep, alcohol limitation, treating sleep apnea if present, and consistent weekly dosing. Hurts results: skipping doses, low protein intake (drives muscle loss and rebound hunger), excess alcohol, untreated sleep apnea, inadequate sleep, and stopping the medication. In trials, patients who stopped semaglutide regained two-thirds of lost weight within a year.
Frequently Asked Questions
Why am I losing weight slower than the average?
Individual response varies. Slower loss can reflect dose still being titrated, insulin resistance, underactive thyroid, sleep deprivation, alcohol intake, hidden calories, or low NEAT (non-exercise activity). A medical review and body composition scan usually clarify.
Will I lose weight forever on GLP-1?
No — weight loss naturally plateaus once you reach a new metabolic equilibrium, typically 12-22 months after starting. Ongoing therapy maintains the result; stopping usually leads to substantial regain.
How do I avoid regain?
Stay on therapy long-term (most physicians treat obesity as chronic, similar to hypertension), maintain protein and resistance training, optimize sleep, limit alcohol, and continue medical follow-up. Step-down or transition strategies exist for select patients but require physician supervision.
Will I lose mostly fat or muscle?
Without intervention, 25-40% of weight lost can be lean mass. With protein intake of 0.7-1.0 g per pound of goal body weight and resistance training, lean loss can be limited to 10-20%, similar to other weight-loss modalities.
Get Help Now
Speak with a Haute MD Internal Medicine physician
Dr. Alexander Golberg
Internal Medicine · New York, NY
View Profile
Dr. Kern Brar
MD
Internal Medicine · Oceanside, CA
View ProfileAre you a Internal Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · WEIGHT LOSS & METABOLIC HEALTH
What Are the Side Effects of GLP-1 Medications?
The most common GLP-1 side effects are nausea, vomiting, diarrhea, and constipation. Less common but serious risks include pancreatitis, gallbladder disease, muscle loss, and thyroid warnings.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
Who Is a Candidate for GLP-1 Therapy?
GLP-1 medications are FDA-approved for type 2 diabetes, chronic weight management (BMI ≥30, or ≥27 with comorbidity), and obstructive sleep apnea. Learn who qualifies and what to expect.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
How Do GLP-1 Medications Work?
GLP-1 medications mimic a gut hormone that suppresses appetite, slows gastric emptying, and improves insulin response — leading to lower blood sugar and significant weight loss.
Read Guide